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Introduction {#sec1}
============

During reprogramming, the inefficient induction and low quality of induced pluripotent stem cells (iPSCs) with abnormal gene expression and chromosome integrity limit potential applications for future clinical therapy ([@bib19], [@bib33]). The telomere is re-elongated after sperm-oocyte binding ([@bib26]). Telomerase activity is high in iPSCs ([@bib40]). The efficiency of chimera generation of iPSCs is higher in cells with longer telomeres than those with short telomeres. Moreover, embryonic stem cells (ESCs) with short telomeres also show reduced teratoma formation and chimera production ([@bib15]). Previous study showed that the reprogramming efficiency of iPSCs derived from mouse embryonic fibroblasts (MEFs) of telomerase gene *Terc*^−/−^ mice was decreased ([@bib30]). Mouse iPSCs with short telomeres show a lower capacity for teratoma formation or chimera production, failing to generate complete pups ([@bib52]). During reprogramming, the re-elongation of telomeres is thus critically important for pluripotency acquisition.

Lengthening of telomeres in iPSCs induced with four factors (*Oct4*, *Sox2*, *c-Myc*, and *Klf4*) is dependent on telomerase activity and is a very slow process, involving several passages after reprogramming to reach similar lengths to ESC telomeres ([@bib30]). By contrast, telomere lengths quickly and extensively increase during somatic cell nuclear transfer (SCNT) reprogramming ([@bib20], [@bib44]). Oocytes contain sufficient factors for efficient high-quality somatic reprogramming using SCNT compared with the limited factors in the induction of iPSCs ([@bib4], [@bib45], [@bib49]). The overexpression of *Zscan4*, an oocyte-related factor, during iPSC induction significantly improved telomere elongation and increased reprogramming efficiency and pluripotency through the telomerase-independent alternative lengthening of telomeres (ALT) ([@bib19], [@bib22]). In addition, the protein complex Shelterin, which contains TERF1, TERF2, POT1, RAP1, TIN2, and TPP1 ([@bib48]), was also important for telomere length and stabilization. *Terf1* has been reported to play a key role in both telomerase-dependent telomere maintenance and the ALT process ([@bib14]). TERF1 co-localizes and interacts indirectly with ZSCAN4 in the cell nucleus ([@bib22]). TERF1, along with TERF2, normally prevents telomerase from adding more telomere units to telomeres to balance the telomere length ([@bib10]). However, when telomere lengthening is required, TERF1 recruits helicases to facilitate the process ([@bib36]). In addition, *Terf1* is highly expressed in ESCs and iPSCs as a stemness marker ([@bib3], [@bib35]). However, whether *Terf1* participates in the regulation of reprogramming telomere re-elongation remains unknown.

Pre-iPSCs, the partially reprogrammed cells, provide a useful model for studying the regulatory mechanism of reprogramming. Pre-iPSCs exhibit ESC-like morphology but show low pluripotency and cannot form chimeras ([@bib38], [@bib47]). Pre-iPSCs could be activated to naive pluripotency cells by inhibitor of mitogen-activated protein kinase (MAPK, PD0325901) and inhibitor of glycogen synthase kinase 3 beta (GSK3B, CHIR99021) with the leukemia inhibitory factor (LIF) culture ([@bib42]). Knockdown of *Hdac2* promotes the four factors that induce iPSC generation and also converts pre-iPSCs into the fully reprogrammed state ([@bib47]). The pre-iPSCs can also be a valuable resource for investigating telomere regulation during iPSC induction.

Recently, a group of microRNAs (miRNAs) were connected to the transcriptional regulatory circuitry of telomere length modulation and pluripotency during the reprogramming of iPSCs. The overexpression of *miR-302/367* inhibited the expression of *Hdac2* to promote efficient iPSC induction ([@bib1]). The *miR-17∼92*, *miR-106b∼25*, and *miR-106a∼363* clusters were highly expressed and inhibited the expression of *transforming growth factor beta receptor 2* (*Tgfbr2*) to promote reprogramming ([@bib24]). *MiR-23a* repressed the expression of *Terf2*, resulting in abnormal telomere function ([@bib29]). *MiR-155* directly targeted *Terf1* to induce telomere fragility ([@bib9]). However, whether miRNAs can regulate telomere-related genes and increase pluripotency during iPSC induction remains largely unknown.

Transforming growth factor beta (TGFB) family genes were reported to inhibit *Tert* expression via the regulation of SMAD3 phosphorylation ([@bib6]). BMP7 induced telomere shortening in breast cancer cells ([@bib5]). The inhibition of signaling substituted for *Oct4* during iPSC induction and maintained pluripotency ([@bib41]). The inhibition of TGFB also promoted the expression of *Nanog* ([@bib18]). In addition, the repression of NODAL/ACTIVIN signaling mediated the function of Polycomb in increasing the reprogramming efficiency ([@bib8]). However, whether TGFB family-related signaling influences telomere elongation and pluripotency of iPSCs during cell reprogramming remains unclear.

Our study showed that *miR-590-3p* and *miR-590-5p* in mature iPSCs and ESCs had increased expression compared with pre-iPSCs. The ectopic expression of *miR-590-3p* and *miR-590-5p* promoted the telomere elongation and pluripotency of pre-iPSCs. We further found that both *miR-590-3p* and *miR-590-5p* upregulated *Terf1* expression by targeting *Activin receptor II A* (*Acvr2a*). This work elucidated the role of the *miR-590*/*Acvr2a*/*Terf1* signaling pathway in modulating pluripotency and telomere elongation in pre-iPSCs.

Results {#sec2}
=======

*miR-590* Is Highly Expressed in Fully Pluripotent Cells and Promotes Telomere Elongation and Pluripotency in Pre-iPSCs {#sec2.1}
-----------------------------------------------------------------------------------------------------------------------

To observe the difference in quality among pre-iPSCs, mature iPSCs, and ESCs, we detected stemness marker expression levels and differentiated these cells into three germ layers. Compared with ESCs and mature iPSCs, pre-iPSCs showed lower expression levels of stemness markers *Oct4*, *Sox2*, *Nanog*, and *Esrrb* ([Figure 1](#fig1){ref-type="fig"}A). In addition, the pre-iPSC cell line used for this research was established in our laboratory for previous study and failed at maturation process ([@bib47]). The immunofluorescence staining indicated that SOX2 and SSEA1 were significantly lower in pre-iPSCs than in mature iPSCs and ESCs ([Figure S1](#mmc1){ref-type="supplementary-material"}A). The expression level of *Nanog*, *Esrrb*, *Rex1*, *Cripto*, and *Sall4* ([Figures 1](#fig1){ref-type="fig"}A and [S1](#mmc1){ref-type="supplementary-material"}B) also confirmed the maturation of iPSCs ([@bib47]). The differentiation potentials to the three germ layers were also decreased in pre-iPSCs ([Figures 1](#fig1){ref-type="fig"}B and [S1](#mmc1){ref-type="supplementary-material"}C). The telomere length of pre-iPSCs cells was significantly shorter than that of the ESCs and mature iPSCs ([Figures 1](#fig1){ref-type="fig"}C and 1D). The expression levels of *miR-590-3p* and *miR-590-5p* were higher in mature iPSCs and ESCs than in pre-iPSCs ([Figure 1](#fig1){ref-type="fig"}E). Then, we enhanced the pre-iPSC maturation by adding the 2i compounds (1 μM PD0325901 and 3 μM CHIR99021) into the medium and found that the stemness markers were upregulated ([Figure 1](#fig1){ref-type="fig"}F) with the telomere elongation ([Figure 1](#fig1){ref-type="fig"}G) during 1 week in pre-iPSCs. We transfected the *miR-590-3p* and *miR-590-5p* inhibitors in the pre-iPSCs and found that inhibition of *miR-590* repressed the pluripotency acquisition of pre-iPSCs treated by 2i ([Figure S1](#mmc1){ref-type="supplementary-material"}D). However, the expression of *Gsk3b* related to the CHIR99021 and *Map2k1* related to the PD0325901 were not significantly changed in the pre-iPSCs transfected with *miR-590-5p* and *miR-590-3p* inhibitors ([Figure S1](#mmc1){ref-type="supplementary-material"}E). Overexpression of *Oct4* could increase the expression level of *miR-590-3p* and *miR-590-5p* ([Figure S1](#mmc1){ref-type="supplementary-material"}F). Our previous study indicated the inhibition of *miR-590* could increase the proliferation of ESCs ([@bib27]). We also confirmed the inhibition of *miR-590* promoted the proliferation of mature iPSCs ([Figure S1](#mmc1){ref-type="supplementary-material"}G). Knockdown of *Rad51b*, the downstream target of *miR-590* ([@bib27]), could also increase the proliferation of mature iPSCs ([Figure S1](#mmc1){ref-type="supplementary-material"}H) but had no significant effect on pluripotency ([Figure S1](#mmc1){ref-type="supplementary-material"}I). During the maturation process of pre-iPSCs, the expression level of *miR-590* was also upregulated ([Figure 1](#fig1){ref-type="fig"}H). Overexpression of *miR-590-3p* or *miR-590-5p* in pre-iPSCs promoted the re-elongation of telomere length compared with the control group ([Figures 1](#fig1){ref-type="fig"}I--1K). Pluripotency was also increased by overexpressing *miR-590* ([Figures 1](#fig1){ref-type="fig"}L and 1M).Figure 1High Expression of *miR-590* in Fully Pluripotent Cells Promotes Telomere Elongation and Pluripotency in Pre-iPSCs(A) qRT-PCR showed the low expression of stemness markers *Oct4*, *Sox2*, *Nanog*, and *Esrrb* in mouse pre-iPSCs compared with ESCs and iPSCs. Data shown are the mean ± SD (n = 5).(B) Detecting markers of three germ layers, including endoderm (*Mixl1*, *Gata6*, and *Afp*), mesoderm (*Gata4*, *T*, and *Snail*), and ectoderm (*Oct6*, *Sox1*, and *Nestin*), derived from mouse ESCs, iPSCs, and pre-iPSCs by qRT-PCR. Data shown are the mean ± SD (n = 3).(C) Fluorescence *in situ* hybridization (FISH) detection of telomere staining in ESCs, iPSCs, and pre-iPSCs showed the shorter length of telomere in pre-iPSCs. The bottom panel shows the statistics of relative telomere length (relative telomere fluorescence intensity) by histogram measured by FISH. Scale bar indicates 10 μm.(D) Relative length of telomeres in ESCs, iPSCs, and pre-iPSCs detected by qPCR. Data shown are the mean ± SD (n = 3).(E) Lower expression of *miR-590-3p* and *miR-590-5p* in pre-iPSCs than in ESCs and iPSCs detected by qRT-PCR. Data shown are the mean ± SD (n = 4).(F) qRT-PCR detection showed the gradual upregulation of stemness markers by 2i induction in pre-iPSCs on 4 days (4d) and 8 days (8d). Data shown are the mean ± SD (n = 3).(G) Telomere could elongate in the 2i-treated pre-iPSCs detected by qPCR. Data shown are the mean ± SD (n = 4).(H) Upregulation of *miR-590-3p* and *miR-590-5p* during the maturation process by 2i treatment. Data shown are the mean ± SD (n = 3).(I) Both *miR-590-3p* and *miR-590-5p* promoted telomere elongation. Data shown are the mean ± SD (n = 3).(J) FISH detection of telomere staining showed improvement in telomere elongation by overexpression of *miR-590-3p* or *miR-590-5p*. Scale bar indicates 10 μm.(K) The statistics of (J).(L) *MiR-590-3p* or *miR-590-5p* overexpression increased the expression level of stemness markers in pre-iPSCs. Data shown are the mean ± SD (n = 3).(M) Three germ layer markers were upregulated in the cells derived from the *miR-590-3p* or *miR-590-5p*-overexpressing pre-iPSCs. Data shown are the mean ± SD (n = 3).For all data, ^∗^ and ^\#^p \< 0.05, ^∗∗^ and ^\#\#^p \< 0.01, ^∗∗∗^ and ^\#\#\#^p \< 0.001. In (A), (B), and (D), the asterisk (^∗^) means the significance in the comparison of ESCs group with the pre-iPSCs group; hash (\#) means the significance of the statistics of the iPSCs and pre-iPSCs group. In other panels, the asterisk means the significance of the comparison of treated cell group with the control (ctrl) group.

Inhibition of *Acvr2a* Improves Telomere Re-elongation to Promote Pluripotency in Pre-iPSCs {#sec2.2}
-------------------------------------------------------------------------------------------

Our previous study identified *Acvr2a* as a downstream target of *miR-590-3p* and *miR-590-5p* ([@bib27]). Here, we found that *Acvr2a* expression was downregulated in pre-iPSCs overexpressing *miR-590* ([Figure 2](#fig2){ref-type="fig"}A). Then, knockdown of *Acvr2a* in pre-iPSCs ([Figure 2](#fig2){ref-type="fig"}B) showed that the telomeres could be elongated ([Figures 2](#fig2){ref-type="fig"}C and 2D). The expression level of stemness markers ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}A) and the differentiation potentials to the three germ layers were both increased after knockdown of *Acvr2a* ([Figures 2](#fig2){ref-type="fig"}F and [S2](#mmc1){ref-type="supplementary-material"}B).Figure 2Inhibition of *Acvr2a* Improves Telomere Re-elongation to Promote Pluripotency in Pre-iPSCs(A) *MiR-590-3p* or *miR-590-5p* downregulated the mRNA level of *Acvr2a* detected by qRT-PCR. Data shown are the mean ± SD (n = 3).(B) Detecting the efficiency of *Acvr2a* knockdown in pre-iPSCs. Data shown are the mean ± SD (n = 3).(C) Downregulation of *Acvr2a* promoted telomere elongation. Data shown are the mean ± SD (n = 3).(D) FISH staining of telomeres and histogram statistics showed the promotion of telomere elongation by downregulating *Acvr2a*. Scale bar indicates 10 μm.(E) Stemness markers were upregulated in *Acvr2a* knockdown pre-iPSCs. Data shown are the mean ± SD (n = 3).(F) *Acvr2a* knockdown increased the pluripotency of pre-iPSCs. Data shown are the mean ± SD (n = 3).For all data, ^∗^p \< 0.05, ^∗∗^p \< 0.01, and ^∗∗∗^p \< 0.001.

The *miR-590*/*Acvr2a* Pathway Modulates Telomere Length and the Pluripotency of Pre-iPSCs {#sec2.3}
------------------------------------------------------------------------------------------

To determine whether *Acvr2a* mediated the function of *miR-590* in regulating telomeres and pluripotency in pre-iPSCs, we performed rescue experiments and found that the overexpression of *Acvr2a* significantly blocked the promotion of telomere re-elongation by *miR-590-3p* overexpression ([Figures 3](#fig3){ref-type="fig"}A and 3B). The expression levels of stemness markers ([Figures 3](#fig3){ref-type="fig"}C and [S3](#mmc1){ref-type="supplementary-material"}A) and three germ layer markers ([Figures 3](#fig3){ref-type="fig"}D and [S3](#mmc1){ref-type="supplementary-material"}B) were blocked by *Acvr2a* overexpression. Furthermore, we co-overexpressed *Acvr2a* with *miR-590-5p* and found that *Acvr2a* could block the telomere re-elongation promoted by *miR-590-5p* overexpression ([Figures 3](#fig3){ref-type="fig"}E and 3F). The expression levels of stemness markers ([Figures 3](#fig3){ref-type="fig"}G and [S3](#mmc1){ref-type="supplementary-material"}A) and three germ layer markers ([Figures 3](#fig3){ref-type="fig"}H and [S3](#mmc1){ref-type="supplementary-material"}C) were also blocked by *Acvr2a* overexpression.Figure 3The *miR-590*/*Acvr2a* Pathway Modulates Telomere Length and the Pluripotency of Pre-iPSCs(A) Telomere FISH staining and histogram statistics (bottom) showed that the overexpression of *Acvr2a* blocked the function of *miR-590-3p* on regulating telomere elongation in the rescue experiments. Scale bar indicates 10 μm.(B) Detection of the telomeres by qPCR in the rescue experiment. Data shown are the mean ± SD (n = 3).(C) *Acvr2a* restored the expression of stemness markers upregulated by *miR-590* to be similar with the control group in the rescue experiment. Data shown are the mean ± SD (n = 3).(D) *Acvr2a* blocked the increase of pluripotency caused by overexpression of *miR-590-3p* in pre-iPSCs. Data shown are the mean ± SD (n = 3).(E and F) (E) FISH staining of telomeres and histogram statistics (right) and (F) qPCR detection both showed that *Acvr2a* blocked the *miR-590-5p* function in promoting telomere elongation. Scale bar indicates 10 μm. Data shown are the mean ± SD (n = 3).(G and H) (G) Detection of the *Acvr2a* function blocking the promotion of stemness marker expression and (H) the pluripotency of differentiation capacity regulated by *miR-590-5p*. Data shown are the mean ± SD (n = 3).For all data, ^∗^ and ^\#^p \< 0.05, ^∗∗^ and ^\#\#^p \< 0.01, ^∗∗∗^ and ^\#\#\#^p \< 0.001. Asterisk (^∗^) means the statistical significance of the *miR-590-5p* and *miR-590-3p* group compared with the control group; hash (\#) means the statistical significance of the *miR-590-5p + Acvr2a* and *miR-590-3p* + *Acvr2a* group compared with the corresponding *miR-590-5p* and *miR-590-3p* group.

*Terf1* Is Critically Involved in Modulating Pre-iPSC Telomere Length and Pluripotency {#sec2.4}
--------------------------------------------------------------------------------------

We performed differential expression analysis of telomere-related genes between mature iPSCs and pre-iPSCs and found that *Terf1* was highly expressed in mature iPSCs and was much higher than in pre-iPSCs ([Figure 4](#fig4){ref-type="fig"}A). So we hypothesized that *Terf1* might play critical role in regulating pre-iPSCs telomere. Overexpression of either *miR-590-3p* or *miR-590-5p* upregulated *Terf1* in pre-iPSCs ([Figure 4](#fig4){ref-type="fig"}B). Furthermore, we found that *Terf1* expression was upregulated during the induction process of iPSCs ([Figure 4](#fig4){ref-type="fig"}C). The overexpression of *Terf1* increased telomere length ([Figures 4](#fig4){ref-type="fig"}D and 4E). In addition, *Terf1* promoted pluripotency acquisition in pre-iPSCs ([Figures 4](#fig4){ref-type="fig"}F, 4G, [S4](#mmc1){ref-type="supplementary-material"}A, and S4B).Figure 4*Terf1* Is Critically Involved in Modulating Pre-iPSC Telomere Length and Pluripotency(A) Relative expression level of telomere-related genes in iPSCs and pre-iPSCs. The *Terf1* expressed highly in mature iPSCs compared with pre-iPSCs. Data shown are the mean ± SD (n = 3).(B) *MiR-590* promoted the expression of *Terf1*. Data shown are the mean ± SD (n = 3).(C) The expression level of *Terf1* was upregulated during cell reprogramming. Data shown are the mean ± SD (n = 3).(D and E) (D) FISH staining of telomeres and histogram statistics (bottom) and (E) qPCR detection indicated that *Terf1* overexpression improved telomere elongation. Scale bar indicates 10 μm. Data shown are the mean ± SD (n = 3).(F and G) (F) *Terf1* promoted stemness marker expression and (G) the pluripotency in pre-iPSCs. Data shown are the mean ± SD (n = 3).For all data, ^∗^p \< 0.05, ^∗∗^p \< 0.01, ^∗∗∗^p \< 0.001.

*Terf1* Mediates the *Acvr2a* Function in Regulating Telomere Elongation and Pluripotency {#sec2.5}
-----------------------------------------------------------------------------------------

After the addition of SB431542 (50 μM), an ACTIVIN signaling inhibitor of p-SMAD2 signaling, into the pre-iPSC culture medium, we found that *Terf1* was upregulated ([Figure 5](#fig5){ref-type="fig"}A). Then, we performed chromatin immunoprecipitation (ChIP) assays to assess the binding of p-SMAD2 to the *Terf1* promoter in pre-iPSCs and found that it was increased compared with binding in mature iPSCs ([Figure 5](#fig5){ref-type="fig"}B). Inhibition of p-SMAD2 by SB431542 also showed more binding of POL II on *Terf1* promoter ([Figure S5](#mmc1){ref-type="supplementary-material"}A). Knockdown of *Acvr2a* also increased the expression of *Terf1* ([Figure 5](#fig5){ref-type="fig"}C). Knockdown of *Terf1* blocked the effect on telomere elongation caused by the downregulation of *Acvr2a* ([Figures 5](#fig5){ref-type="fig"}D and 5E). In addition, knockdown of *Terf1* blocked the promoting effect of *Acvr2a* downregulation on pluripotency ([Figures 5](#fig5){ref-type="fig"}F, 5G, [S5](#mmc1){ref-type="supplementary-material"}B, and S5C).Figure 5*Terf1* Mediates the *Acvr2a* Function in Regulating Telomere Elongation and Pluripotency(A) Inhibition of ACTIVIN signaling by SB431542 increased *Terf1* expression. Data shown are the mean ± SD (n = 3).(B) ChIP assays indicated that p-SMAD2 shows increased binding to the *Terf1* promoter in pre-iPSCs compared with mature iPSCs. "Ctrl region" means the sequence without p-SMAD2 binding, while "Pr region" means the prediction region of p-SMAD2 in promoter. Data shown are the mean ± SD (n = 3).(C) Downregulation of *Acvr2a* upregulated the expression of *Terf1*. Data shown are the mean ± SD (n = 3).(D and E) (D) Pre-iPSCs with *Terf1* knockdown blocked the increase in telomere elongation promoted by downregulation of *Acvr2a*, which was detected by both qPCR and (E) FISH assays. Scale bar indicates 10 μm. Data shown are the mean ± SD (n = 3).(F and G) (F) Downregulation of *Terf1* prevented the function of *Acvr2a* knockdown in promoting stemness marker expression and (G) pluripotency in pre-iPSCs. Data shown are the mean ± SD (n = 3).For all data, ^∗^ and ^\#^p \< 0.05, ^∗∗^ and ^\#\#^p \< 0.01. Asterisk (^∗^) means the statistical significance of the shR-*Acvr2a*-1 and shR-*Acvr2a*-2 group compared with the control group; hash (\#) means the statistical significance of the shR-*Acvr2a*-2+si*Terf1* group compared with the shR-*Acvr2a*-2 group.

*Terf1* Is the Functional Downstream Mediator of *miR-590* in Regulating Telomere Elongation and Pluripotency {#sec2.6}
-------------------------------------------------------------------------------------------------------------

We performed rescue experiments and found that the downregulation of *Terf1* blocked the *miR-590-3p*-mediated increase in telomere elongation ([Figures 6](#fig6){ref-type="fig"}A and 6B). The expression levels of pluripotent genes ([Figures 6](#fig6){ref-type="fig"}C and [S6](#mmc1){ref-type="supplementary-material"}A) and three germ layer markers ([Figures 6](#fig6){ref-type="fig"}D and [S6](#mmc1){ref-type="supplementary-material"}B) were also blocked by knockdown of *Terf1* in *miR-590-3p*-overexpressing pre-iPSCs. Similarly, downregulation of *Terf1* blocked the re-elongation of telomeres promoted by *miR-590-5p* overexpression ([Figures 6](#fig6){ref-type="fig"}E and 6F). Moreover, the expression levels of pluripotent genes ([Figures 6](#fig6){ref-type="fig"}G and [S6](#mmc1){ref-type="supplementary-material"}A) and three germ layer markers ([Figures 6](#fig6){ref-type="fig"}H and [S6](#mmc1){ref-type="supplementary-material"}C) were similar to the control groups following the downregulation of *Terf1* with the overexpression of *miR-590-5p* in pre-iPSCs.Figure 6*Terf1* Is the Functional Downstream Mediator of *miR-590* in Regulating Telomere Elongation and Pluripotency(A) FISH assays showed that downregulation of *Terf1* blocked the improvement of telomere elongation caused by the *miR-590-3p* overexpression in the rescue experiment. Scale bar indicates 10 μm.(B) qPCR detection of telomere length in the rescue experiment. Data shown are the mean ± SD (n = 4).(C) Increased expression of stemness markers by *miR-590-3p* was prevented by *Terf1* knockdown. Data shown are the mean ± SD (n = 4).(D) Detection of three germ layer markers by qPCR showed that *Terf1* downregulation blocked the improvement of pluripotency acquisition through *miR-590-3p*. Data shown are the mean ± SD (n = 3).(E and F) (E) Downregulation of *Terf1* also blocked the *miR-590-5p* function of promoting telomere elongation as detected by both FISH and (F) qPCR. Scale bar indicates 10 μm. Data shown are the mean ± SD (n = 3).(G and H) (G) Downregulation of *Terf1* prevented *miR-590-5p*-mediated promotion of stemness marker expression and (H) pluripotency in pre-iPSCs. Data shown are the mean ± SD (n = 3).For all data, ^∗^ and ^\#^p \< 0.05, ^∗∗^ and ^\#\#^p \< 0.01, ^∗∗∗^ and ^\#\#\#^p \< 0.001. Asterisk (^∗^) means the statistical significance of the *miR-590-5p* and *miR-590-3p* group compared with the control group; hash (\#) means the statistical significance of the *miR-590-5p* + si*Terf1* and *miR-590-3p* + si*Terf1* group compared with the corresponding *miR-590-5p* and *miR-590-3p* group.

Discussion {#sec3}
==========

iPSC induction remains an inefficient process ([@bib39]). Although studies have suggested that chemical compounds ([@bib7], [@bib23]) that regulate some gene expression signaling pathways ([@bib12], [@bib50]) or that promote epigenetic alteration with reprogramming factors ([@bib16], [@bib37]) increase the quality and efficiency of iPSCs, how cells re-elongate their telomeres remains largely unknown. Our study showed that *miR-590* can target *Acvr2a* to upregulate the expression of *Terf1* and finally promote the elongation and pluripotency of pre-iPSCs.

Efficient telomere elongation is critically involved in the gain of pluripotency and is the key factor ensuring the higher quality of iPSCs ([@bib30]). For ESCs, in addition to higher expression of telomerase genes and activity, *Zscan4*, which participates in the ALT process, increases the frequency of sister chromatid exchange to promote recombination ([@bib51]). A previous study showed that *Zscan4* combined with the reprogramming factors promoted iPSC induction, quality, and telomere elongation with decreased DNA damage ([@bib19]). However, compared with the ALT process of efficient telomere elongation by utilizing SCNT ([@bib44]), the induction of iPSCs by telomerase-dependent telomere elongation using four factors is inefficient ([@bib21]). In this study, we found that pre-iPSCs showed much shorter telomere lengths and lower pluripotency than ESCs or mature iPSCs. Coincidentally, *miR-590* showed higher expression in ESCs and mature iPSCs. Previous studies showed that *miR-590* increased both calcium deposition and the osteoblast differentiation marker genes' expression in mouse mesenchymal stem cells ([@bib43]). *MiR-590* could prevent the progression of aortic atherosclerosis in apolipoprotein E knockout mice ([@bib13]). In addition, *miR-590* was also reported to be the epithelial-mesenchymal transition suppressor and downregulated in unilateral ureteral obstruction kidney mouse model ([@bib28]). These studies suggested the critical roles of *miR-590* on many kinds of physiology process. Further ectopic expression of *miR-590-3p* or *miR-590-5p* in pre-iPSCs significantly promoted telomere elongation and the pluripotency of pre-iPSCs. In addition, cell reprogramming may result in abnormal chromosomes ([@bib11], [@bib17]). Our previous study indicated the role of *miR-590* in promoting DNA damage repair in mouse ESCs (mESCs) ([@bib27]). These results suggested the critical function of *miR-590* during cell reprogramming by improving telomere elongation, genome stability, and cell pluripotency.

MiRNAs have been reported to be key regulators in ESCs and iPSCs and to participate in many molecular signaling pathways ([@bib24], [@bib25], [@bib34]). Our previous study reported that *miR-590* directly targets *Acvr2a*, which belongs to the TGFB superfamily to enhance ESC self-renewal and DNA damage repair ([@bib27]). TGFB family genes that play important roles in ESCs and iPSCs can also be regulated by miRNAs ([@bib41]). It has been reported that *miR-590* directly targets *Acvr2a* to enhance ESC self-renewal and DNA damage repair ([@bib27]). The *miR-302/367* cluster regulates the TGFBR2/E-CADHERIN pathway to accelerate the mesenchymal-epithelial transition process during reprogramming ([@bib25]). Our study indicated that downregulation of *Acvr2a* promoted telomere elongation and pluripotency in pre-iPSCs. Rescue experiments confirmed that *Acvr2a* mediated the function of *miR-590*. These results identified the function of the TGFB family receptor gene *Acvr2a* and the *miR-590*/*Acvr2a* signaling pathway in modulating telomere elongation and reprogramming.

Telomere-related genes have been reported to be regulated by TGFB family members. Telomerase TERT can be repressed by the TGFB/p-SMAD3 pathway ([@bib6], [@bib46]). SMAD3 is recruited by OCT4 to restrict *Rif1* expression by binding to its promoter to maintain the stability of mESCs. Deletion of *Terf1* in iPSCs induced DNA damage with an increasing number of γH2AX-positive cells ([@bib35]). In MEFs, downregulation of *Terf1* inhibited cell proliferation ([@bib31]). Terf1 is important to recruit helicases to facilitate telomere lengthening ([@bib36]). Previous study of the impairment of generation of iPSCs derived from the MEFs of second- and third-generation telomerase-deficient mice found that that telomeres no longer elongated and were shortening continuously during the reprogramming. In addition, although the induction efficiency of *Terc*^−/−^ iPSCs derived from first-generation MEFs of telomerase-deficient mice was similar to wild-type controls, the generation of chimeric mice failed ([@bib30]). Here we found that inhibition of p-SMAD2 increased the expression of *Terf1* in pre-iPSCs, elongated the telomere, and led to the maturation of pre-iPSCs. Overexpression of *Terf1* itself also promoted the telomere elongation and the maturation of pre-iPSCs. These results collectively indicated the importance of the re-elongation of short telomeres for normal iPSC generation and maturation.

Further, we determined that inhibition of ACTIVIN signaling by SB431542 or the downregulation of *Acvr2a* increased *Terf1* expression. These results suggested the function of ACTIVIN signaling in regulating *Terf1* expression. Our rescue experiments found that *Terf1* mediated the function of *Acvr2a* in regulating telomere elongation and pluripotency in pre-iPSCs. We further determined that *Terf1* is a functional downstream mediator of the *miR-590*/*Acvr2a* pathway and forms the *miR-590*/*Acvr2a*/*Terf1* axis. In addition, a previous study indicated that *Zscan4* participates in the ALT process to improve telomere elongation and the quality of iPSCs ([@bib19]). TERF1 not only interacts with ZSCAN4 but also regulates the ALT process ([@bib22]). These results suggested the critical function of *Terf1* and the *miR-590*/*Acvr2a*/*Terf1* signaling pathway in improving the quality of iPSCs. Our previous study showed the *miR-590* was upregulated during the differentiation of mESCs after LIF withdrawal. *MiR-590* could regulate the expression of *Rad51b* to balance the DNA damage and cell cycle but could not influence the pluripotency of mESCs ([@bib27]). Interestingly, here we found that *miR-590* was highly expressed in ESCs and iPSCs compared with pre-iPSCs. The expression of *miR-590* was also upregulated during the pre-iPSCs' maturation promoted by 2i (CHIR99021 and PD0325901). We found that inhibition of *miR-590* repressed the pluripotency acquisition of pre-iPSCs treated by 2i. This result indicated the important role of *miR-590* during the reprogramming, and the aberrant inhibition of *miR-590* expression during reprogramming might arrest the reprogramming cells in the pre-iPSC status. These findings also indicated that the regulatory mechanism of *miR-590* expression might be different during iPSC reprogramming and mESC differentiation. Our study elucidated the role of the *miR-590*/*Acvr2a*/*Terf1* signaling axis in improving telomere elongation and pluripotency of pre-iPSCs, establishing a foundation for the clinical application of iPSCs in the future.

Experimental Procedures {#sec4}
=======================

Cell Culture {#sec4.1}
------------

Mouse ESCs were cultured in 15% fetal bovine serum (FBS) (Gibco), while iPSCs and pre-iPSCs were cultured in 20% knockout serum replacement (KOSR) (Gibco) of knockout-DMEM (Gibco) medium. The medium also contained 1% nonessential amino acids (NEAAs) (Thermo), 1% mM L-glutamine (Thermo), 55 μM β-mercaptoethanol (Gibco), and LIF (Millipore). Cells were maintained on feeders at 37°C in a humidified 5% CO~2~ atmosphere. The pre-iPSCs have been reported in our previous study ([@bib47]).

qRT-PCR {#sec4.2}
-------

Total RNA was isolated using RNAiso Plus (TaKaRa). cDNA synthesis from mRNA and miRNAs was performed using the cDNA Synthesis Kit (TaKaRa) and the TIANScript RT Kit (TIANGEN), respectively. The Bulge-Loop miRNA qPCR Primer Set was purchased from the RiboBio Company. Primers for the qRT-PCR analysis of mRNA are shown in [Table S1](#mmc1){ref-type="supplementary-material"}.

Immunofluorescence Staining of Three Germ Layers {#sec4.3}
------------------------------------------------

For the differentiation of three germ layers, cells were cultured in the medium for 48 hr, followed by withdrawing the LIF for another 7-day culture process. Medium should be changed every day. Then the differentiation cells were used for staining. First, cells were fixed with 4% paraformaldehyde (PFA) for 20 min and permeabilized with 0.2% Triton X-100 for 8 min. Cells were washed with PBS and blocked with 10% FBS (Gibco) for 1 hr at room temperature. Then, cells were stained with primary antibodies against SOX2 (Abcam, ab59776), SSEA1 (Santa Cruz, sc-101462), GATA4 (Santa Cruz, sc-9053), GATA6 (R&D Systems, AF1700), and NESTIN (Abcam, ab105389) for 12 hr at 4°C. After washing with PBS, cells were incubated with the corresponding secondary antibodies. Finally, cells were counterstained with Hoechst33342 (Sigma, 14533) to show the entire cell nucleus.

Fluorescence *In Situ* Hybridization Assay {#sec4.4}
------------------------------------------

Chromosomes were separated onto glass slides and dried overnight. Chromosomes with telomeres were denatured at 80°C for 10 min to hybridize with the red Cy3-labeled telomere peptide nucleic acid probe. Whole chromosomes were stained with 0.5 μg/mL Hoechst33342 (blue). Fluorescence of the chromosomes and telomeres was digitally imaged on a Nikon confocal laser scanning microscope with fluorescein isothiocyanate/DAPI filters. Relative telomere length was presented as telomere fluorescence intensity detected using the TFL-TELO software program.

qPCR Analysis of Relative Telomere Length {#sec4.5}
-----------------------------------------

DNA of cells was isolated using a DNA isolation kit (TIANGEN). Measurements were performed as described in previous studies ([@bib2], [@bib32]).

ChIP Assay {#sec4.6}
----------

ChIP assays were performed with rabbit IgG (Cell Signaling Technology, 2729S), p-SMAD2 (Cell Signaling Technology, 3101L), POL II (Millipore, 05-263) antibodies using the ChIP assay kit (Millipore) according to the instructions. Both immunoprecipitated DNA and whole-cell DNA were used for qPCR assays of *Terf1* with the following primers: for the binding region, 5′-GAAGGGGAAGAGGGAGTGAG-3′ (forward) and 5′-TTGTCAGGCACCTGTCTCAG-3′ (reverse); for the control region, 5′-TCAGGAATGTCCCCTGAGAT-3′ (forward) and 5′-GCATTCCCTTCGGGTATTTT-3′ (reverse).

RNAi Assay {#sec4.7}
----------

For *Terf1*, the siRNA was used for RNAi by targeting the sequence GGAAGUUACUUAAGAUAAUCU (si*Terf1*) in the rescue experiments. Details of the shRNA-*Acvr2a* vectors have been reported in our previous study ([@bib27]).

Statistical Analysis {#sec4.8}
--------------------

The error bars represent the SD of at least three independent experiments. The statistical significance was analyzed by one-way ANOVA or Student\'s t test. ^∗^ and ^\#^p \< 0.05, ^∗∗^ and ^\#\#^p \< 0.01, ^∗∗∗^ and ^\#\#\#^p \< 0.001.
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